159 related articles for article (PubMed ID: 25926387)
1. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.
Nash SH; Schenk JM; Kristal AR; Goodman PJ; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Song X; Gurel B; De Marzo A; Platz EA
Cancer Prev Res (Phila); 2015 Jul; 8(7):590-6. PubMed ID: 25926387
[TBL] [Abstract][Full Text] [Related]
2. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men.
Ritch CR; Wan RL; Stephens LB; Taxy JB; Huo D; Gong EM; Zagaja GP; Brendler CB
J Urol; 2007 Jan; 177(1):97-101; discussion 101. PubMed ID: 17162011
[TBL] [Abstract][Full Text] [Related]
3. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.
Brasky TM; Till C; White E; Neuhouser ML; Song X; Goodman P; Thompson IM; King IB; Albanes D; Kristal AR
Am J Epidemiol; 2011 Jun; 173(12):1429-39. PubMed ID: 21518693
[TBL] [Abstract][Full Text] [Related]
4. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
[TBL] [Abstract][Full Text] [Related]
5. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
Bassett JK; Severi G; Hodge AM; MacInnis RJ; Gibson RA; Hopper JL; English DR; Giles GG
Int J Cancer; 2013 Oct; 133(8):1882-91. PubMed ID: 23575905
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Murtola TJ; Gurel B; Umbehr M; Lucia MS; Thompson IM; Goodman PJ; Kristal AR; Parnes HL; Lippman SM; Sutcliffe S; Peskoe SB; Barber JR; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):463-9. PubMed ID: 26715424
[TBL] [Abstract][Full Text] [Related]
7. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer.
Harvei S; Bjerve KS; Tretli S; Jellum E; Robsahm TE; Vatten L
Int J Cancer; 1997 May; 71(4):545-51. PubMed ID: 9178806
[TBL] [Abstract][Full Text] [Related]
9. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
[TBL] [Abstract][Full Text] [Related]
10. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.
Gurel B; Lucia MS; Thompson IM; Goodman PJ; Tangen CM; Kristal AR; Parnes HL; Hoque A; Lippman SM; Sutcliffe S; Peskoe SB; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):847-56. PubMed ID: 24748218
[TBL] [Abstract][Full Text] [Related]
12. The association of fatty acids with prostate cancer risk.
Newcomer LM; King IB; Wicklund KG; Stanford JL
Prostate; 2001 Jun; 47(4):262-8. PubMed ID: 11398173
[TBL] [Abstract][Full Text] [Related]
13. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
Astorg P
Cancer Causes Control; 2004 May; 15(4):367-86. PubMed ID: 15141138
[TBL] [Abstract][Full Text] [Related]
14. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
15. Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study.
Pot GK; Geelen A; van Heijningen EM; Siezen CL; van Kranen HJ; Kampman E
Int J Cancer; 2008 Oct; 123(8):1974-7. PubMed ID: 18661525
[TBL] [Abstract][Full Text] [Related]
16. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
[TBL] [Abstract][Full Text] [Related]
18. [Dietary fatty acids and colorectal and prostate cancers: epidemiological studies].
Astorg P
Bull Cancer; 2005 Jul; 92(7):670-84. PubMed ID: 16123006
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial.
Chadid S; Song X; Schenk JM; Gurel B; Lucia MS; Thompson IM; Neuhouser ML; Goodman PJ; Parnes HL; Lippman SM; Nelson WG; De Marzo AM; Platz EA
Nutr Cancer; 2022; 74(1):141-148. PubMed ID: 33511883
[TBL] [Abstract][Full Text] [Related]
20. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
